Skip to main content
Caplight Logo









Gemelli Biotech

Gemelli Biotech

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://gemellibiotech.com

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$28.35M

Company Overview

Gemelli Biotech operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Series A round in June 2022.

Gemelli Biotech is a biotechnology company that develops medical devices for diagnosing conditions related to the human microbiome through blood and breath tests.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Gemelli Biotech Comparables

Compare Gemelli Biotech with similar companies based on industry and business-model similarity.

Gemelli Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Commonwealth Diagnostics International
92%
AllClear Healthcare
86%
Aerodiagnostics, LLC
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Gemelli Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
DebtMar 26, 2021
SeedJun 27, 2019
SeedNov 27, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Gemelli Biotech Investors

Notable investors and investment history

Gemelli Biotech investors
InvestorRounds
CerraCap Impact Venture CapitalSeries A
Blue Ox Healthcare PartnersSeries A

Gemelli Biotech Filings

Explore SEC and related filing metadata, where available.

Gemelli Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Gemelli Biotech's valuation, stock price, and market status.

Is Gemelli Biotech a public or private company?

Gemelli Biotech is a private company.

What is the current stock price of Gemelli Biotech?

Gemelli Biotech is a private company, so its shares have no public market price. Caplight tracks Gemelli Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Gemelli Biotech worth (valuation)?

Valuation information for Gemelli Biotech is not publicly available.

Can I buy Gemelli Biotech stock?

Gemelli Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Gemelli Biotech's last funding round?

Gemelli Biotech's most recent funding round was Series A on June 22, 2022.

Who are the main investors in Gemelli Biotech?

Key investors in Gemelli Biotech include Blue Ox Healthcare Partners.

Will Gemelli Biotech IPO soon?

No public IPO plans have been announced for Gemelli Biotech.

How can I track Gemelli Biotech secondary market activity?

Caplight tracks bids, offers, and trades in Gemelli Biotech's shares on secondary markets.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range18
Year Founded2018
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?